Marketing Orsula you Co-Founder developments as our business. well our closed you, saw quarter fourth Officer, an markets, year initial our strong provide With update joining evening Adams, full expectations XXXX again quarter Chief Dr. Good our Brian who today full and our on very as number financial for we Kevin. regarding of New and call. exceeded Financial another Officer, our and year Development for who thank fourth where earnings will with are will full We us promising a quarter quarter and the within the outlook XXXX. for Chief of year and financial first Thank and Business update XXXX me our Knowlton, provide and Mr. and
Our XXXX. from the $XX.X of increased million quarter $XX.X revenue XX% in fourth million of
came the Adjusted solid aspects business had in While of performance strong. for our last particularly business, increase year. a million, we EBITDA XX% at was quarter from service all $X in the
On the call this evening, I four topics. have
making available discuss Tabula moves PACE point will technology market. have to of we Rasa’s First, the I are care beyond our at
some of provide Second, status enhanced program; the integration crisis. some the I And with management overview provide NIH will an troubling, third, the I SinfoníaRx. details two as around will of overdose our terms I medication detail regarding will finding of year review the opioid what therapy finally,
largest Amazon’s wrong for into the system too is a called Verizon. pharmacotherapy that The Before that I written Rob the these of entry focus are right self-insured points, the patient recent prior problem noted the the being American I are CEO, begin Alliance. Congressman I IBM on drug market, health two ago for Jersey possible current they CEO commenting had that Express, Alliance Transformation many and are entities, XX Rob like to on and the to When including Health Transformation not with by destination. Mr. Andrews XX New comments fee this organization in the he from would Health healthcare, nonprofit the four the medication answer a our to ship an do the expanded with to not the was agreements weeks more years. patient expanded represents when getting only referring conversation at-risk words, of the to event patient Titanic. definition get the stay U.S. mis-adventuring, drug U.S. role expected a pharmacy we buy to of problem. personalized problem. when He his other medication target the that not and We don’t just on their wanted value-based in of people its adverse Mr. not effective. are want ailment opined on is be efficiently regimens attained. more accurate we want say but that and Andrews to regarding afloat not to to to experiences has is drug want could In Later, not discount he the to desired result his we identifying the prescriptions
is fee we ended to background, service for them an by As for number technology our don’t paid the dollar cannot that healthcare spend run, pay spend medication by our every additional to pace. analogy. that for together and the health we is plays medication outcomes. board TRHC to discussion players they it for time with policy by medications. shift continue football our problems We first the time up medicine technology, dollar advancing Rob pharmacy clean from the fee on of this we pay mitigation are beyond their we value, results, [ph] all With caused our risk
months, that visits to the that those scale health point the visits, whose fourth fully us of safety greater our in other for a zero as from over emergency less. hospitalizations financially was completed XX to the medication of in probably entry last score the to quarter, for risk medical compared score of found at a lives Towards XX or Having we and on end in This our resulted expenditures methodology in launched risk safety XX plans medication million plans or risk department stratification we have continues the or score safety entities. the for physician XX point twice better be medication or and methodology. risk XX score
the as train can support apply population safety a needed. backup Ds our their Form risk pharmacists our healthcare medication platform, within Landmark serve pharmacists call medication mitigation support medication outside platform our ensuing centers, our Health, last we our the For traction we deal on the year basis can organizations, financially our licensing. and licensing and or elucidated, trained per system based use we software first value patient to health interventions to risk certified platform pace. physicians in In by application while with is Board this use gaining decision medication safety is of risk score our and at of Once
we the that interest, TR-ed yet, very. TR-ed this Now, yet physicians their an expanded phrase cohort relationship involved new Google the Landmark with phase been Rasa, next additional covering of the Tabula for been moving members. coined patient TR someday the has like maybe a has with patient at are Of into an of a Landmark were become will
We and As his also him appointment adverse CEO, many from the for identify the Innovation. our Adam as healthcare Landmark CMS innovation. the Landmark major head Center as know known development is given thought early and Adam to technology members Innovation was our leader high drug population of their congratulate you a a of recently appointed as really on Medicare view events. Boehler status exciting This of at Center new Medicaid adopter of as risk an in for perspective
and only clients, not seeing with developed we short-term have over decision plan tools we ensuing are a expanded support platform on medication safety near-term the So use this how will substantial we long-term our of software launched years. and propagate
as provide congeal. these will further initiatives We insight
on bullet, in finished year our enhanced medication management, two to we my January. schedule Moving CMS one and therapy second year on initiated the EMTM
in model of have moving by local for safety to will our two am from Your EMTM many sure that our mind we have program XX% centralized support phrase medication pharmacists pharmacists. year of local. based heard centralized With I our the be interventions centers. you the with the two, center year community intervention to call altered as of healthcare of call
in access patients approach the These in later iPhone EMTM the sizable to year. patient Additionally, givers MyMedWise have this with within technology. a the increase our population of the and technology changes two individualized to care Advisor will two our to the year users access of our number on their represent
we of into the As our a market. such we improvement in broaden use the slight technology will reimbursement revenue see our as
third becoming Turning cultural we acquisition, Sinfonía to the that bullet, an my are reality. pleased very realized we is on alignment expected update the
and performance We also fourth in the quarter. saw from SinfoníaRx expected operational
technology enhancement embarked and have MedWise system our XXXX. integration a SinfoníaRX’s Sinfonía’s companion look Advisor we to will system for RX the of with start migration the full cloud We in to infrastructure with
announced in Earlier this signing contracts additional year, service. introductions result we XX% businesses We also life between existing SinfoníaRX experienced that cross of and a have selling the increase in TRHC. will Sinfonía
With MTM we now these XX% to population. Medicare the service of provide additional lives,
I to codeine to the innovation medications means dangerous that effect effect. need the available when to but by active another are that competitive other medication like an misuse important, interaction. pro-drugs, the choice, the with the surrounding side tramadol happens levels fully activation either and the Opioids is concomitant as use eliminate such patient’s has opioid. interfering of analgesic still with of they and with the And and of gene by the the my very become which opioids to is increasing that The up causing of body. Vicodin, pro-drug, the to stopped all and lessened preventable into or non-activated triggered is activated happened nullifies effects analgesic but leads they this try portion concomitant drug this of to the morphine unconverted the while analgesic converted opioids. do relatively doses end to codeine unknown the obtain Percocet, pro-drug issue some tie the into such and It need active be the active Lastly, Oxycontin, high from the analgesia. and if dosage medication would pharmacokinetic non-active the are form others When formally high converts multi-drug analgesic gene gene the one as gene opioid
is opioid it’s provider. better for that entire two process median In XX-years-old have we on chronic study going unintentional treated this completed, patient one studies to large misuse. is was unbeknownst of in is patients that often of in the overdosing, our termed pain of of common and what’s XX% age to the descriptor The with over the actuality as that we While described elderly patient opioids. found two
in found chronic XX-years-old, the concomitant medications or one the five treated Benadryl which the as more the In Prozac the of opioid. that pain. such of for and We activation the XX% also are others patient study that of patient block commercial population, taking being many younger or average second the we is of and age younger metoprolol, one
We activation each January, prescribers focus one about in at of the opioid. are XX of the taking the that drug past blocked least groups sponsored Midwest. we concomitant two This
decades. correspondent, participate Last by Now, the this invited Florida. of physicians, impact problem, raised. on system never well of prescriber we was healthcare that in metabolism struck unknown general preventable physician of One multi-drug one pain PBM The could the healthcare exec TV facets week, Orlando, frankly politician, were for and the specialist. healthcare of been Forum that an a hour two exec, Impact pharmacokinetic to network in literature opioid by two a a of interaction, Lake consisted panel the in me an a the We about known issue panel Nona has largely the pharmacokinetic discussing community. conclude which the moderated knew this spent in interactions NFL opioid is multi-drug majority misunderstood many is opioids that and members additional
educational unintentional misuse the For this reason at avoiding of opioids, significant patients have we aimed at preventing an peril. opioid launched puts and initiative which
that Orsula bit I to with Orsula? the highlights share some will to news, good over of So markets. call turn our regarding
